NEW YORK (GenomeWeb News) – Five international synthetic genetics companies have started a consortium that will focus on developing best practices for biosecurity protocols.

The International Gene Synthesis Consortium (IGSC), made up of Blue Heron Biotechnology, DNA2.0, GeneArt, GenScript and Integrated DNA Technologies, said today that it will work with governments and other interested parties to support efforts to keep gene synthesis technologies from being misused.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.